About CytoAgents
CytoAgents is a private company based in Pittsburgh, Pennsylvania, incorporated in 2018 in Delaware. It has reported $13,109,738 raised in two offerings on Form D since August 2021. Its chief executive is Teresa Whalen.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 3, 2023 | May 16, 2023 | $7,003,238of $15.2M target | 23 | $304K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 30, 2021 | Aug 12, 2021 | $6,106,500of $6.5M target | 23 | $265K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $13,109,738 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CytoAgents's Form D filed May 16, 2023.
RP
Roy Prieb
Chief Financial Officer
RF
Robert Ferris
Director
SM
Stanley Marks
Director
TW
Teresa Whalen
Chief Executive Officer and President, director
AM
Anthony McCarley
Director
CM
Catherine Mott
Director
Earlier filings also listed John Friedman (director, last listed Aug 2021).